 BOCA RATON, Fla., Jan. 13, 2023 GLOBE NEWSWIRE First Wave BioPharma, Inc. NASDAQ:FWBI First Wave BioPharma or the Company, a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal GI diseases, today announced that the Companys stockholders have approved all proposals voted on at the Companys special meeting of stockholders the ... The post First Wave BioPharma Announces Results of Special Meeting of Stock... 